EP Patent

EP4331620A3 — Lipidic nanoparticles for mrna delivery

Assigned to Translate Bio Inc · Expires 2024-12-04 · 1y expired

What this patent protects

Disclosed herein are compositions for modulating the production of a protein in a target cell, in particular for ameliorating diseases associated with protein or enzyme deficiencies. The compositions comprise at least one mRNA encoding a polypeptide of interest, and a transfer ve…

USPTO Abstract

Disclosed herein are compositions for modulating the production of a protein in a target cell, in particular for ameliorating diseases associated with protein or enzyme deficiencies. The compositions comprise at least one mRNA encoding a polypeptide of interest, and a transfer vehicle comprising a lipid nanoparticle or a lipidoid nanoparticle.

Drugs covered by this patent

Patent Metadata

Patent number
EP4331620A3
Jurisdiction
EP
Classification
—
Expires
2024-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Translate Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.